Dr Ben LaHood, Prof Damien Gatinel, and Sam Carter discuss the latest advancements in RayTrace, including the integration of Gatinel’s PEARL-DGS formula. This new feature leverages AI to improve RayTrace’s predictive accuracy and optimise results by factoring in IOL curvature and effective lens position.
Bios:
Dr Ben LaHood, refractive cataract and laser vision correction surgeon from Australia, has gained international recognition for his extensive research on ast...
Dr Ben LaHood, Prof Damien Gatinel, and Sam Carter discuss the latest advancements in RayTrace, including the integration of Gatinel’s PEARL-DGS formula. This new feature leverages AI to improve RayTrace’s predictive accuracy and optimise results by factoring in IOL curvature and effective lens position.
Bios:
Dr Ben LaHood, refractive cataract and laser vision correction surgeon from Australia, has gained international recognition for his extensive research on astigmatism management and biometry, which is regularly shared around the world. Additionally, Dr Ben LaHood is the host of two widely popular ophthalmology-themed podcasts.
Professor Damien Gatinel is the Head of the Department of Refractive and Anterior Segment Surgery at the Rothschild Foundation Hospital in Paris. He is the co-inventor of the first trifocal IOL, and devised a new classification for HOAs in his applied mathematics PhD thesis. With his colleague, Alain Saad, he developed an AI system for the detection of ectasia-susceptible eyes, the SCORE analyser.
Sam Carter is the Head of Clinical Planning and Outcomes at Rayner. Based in Kuala Lumpar, Malaysia, he brings experience from previous roles at Lenstec UK, Topcon GB Ltd, and Zeiss Medical Technology. Carter additionally holds a 2023-2024 Post Graduate Diploma in Cataract and Refractive Surgery from Ulster University, one of only a handful of non-ophthalmologists to gain this certification.
This podcast is provided for general information purposes only. The presenters’ views are their own. Nothing contained within this podcast is intended to offer medical advice for the treatment of any illness or disease, nor is it a substitute for professional medical advice, diagnosis or treatment. Nothing presented in this podcast is intended to give instruction or guidance on the use of any Rayner products; it is not designed to replace a surgeon's independent judgement about the appropriateness or risks of a procedure for a given patient. Rayner does not endorse off-label use. Users must refer to the product labelling and instructions for use for Rayner products in all cases. Not all Rayner products are available in all countries.
© 2025 Rayner Group, all rights reserved. Rayner, RayTrace and RayPRO are proprietary marks of Rayner. All other trademarks are property of their respective owners. Rayner, 10 Dominion Way, Worthing, West Sussex, BN14 8AQ. Registered in England: 615539
View more
